Kenneth Ng

2.2k total citations
48 papers, 1.2k citations indexed

About

Kenneth Ng is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Kenneth Ng has authored 48 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 23 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in Kenneth Ng's work include Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (12 papers) and Cancer Treatment and Pharmacology (10 papers). Kenneth Ng is often cited by papers focused on Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (12 papers) and Cancer Treatment and Pharmacology (10 papers). Kenneth Ng collaborates with scholars based in United States, Singapore and United Kingdom. Kenneth Ng's co-authors include Mark G. Kris, Vincent A. Miller, Lee M. Krug, Robert T. Heelan, Barbara Pizzo, Christopher G. Azzoli, Stefan C. Grant, Scott A. Laurie, William P. Tong and Naiyer A. Rizvi and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Kenneth Ng

47 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenneth Ng United States 19 469 384 327 133 128 48 1.2k
Toshimitsu Yamaoka Japan 21 645 1.4× 525 1.4× 529 1.6× 107 0.8× 35 0.3× 51 1.4k
Hang Zheng China 17 368 0.8× 197 0.5× 663 2.0× 111 0.8× 82 0.6× 39 1.3k
William G. Nelson United States 16 323 0.7× 612 1.6× 548 1.7× 230 1.7× 42 0.3× 21 1.6k
Loredana Santo United States 16 582 1.2× 155 0.4× 510 1.6× 123 0.9× 34 0.3× 39 1.2k
Peng Chen China 17 467 1.0× 405 1.1× 448 1.4× 75 0.6× 28 0.2× 113 1.2k
Nilgün Kapucuoğlu Türkiye 20 304 0.6× 137 0.4× 253 0.8× 120 0.9× 33 0.3× 74 1000
C Shih United States 14 448 1.0× 476 1.2× 646 2.0× 87 0.7× 591 4.6× 22 1.8k
Tatsuya Rikimaru Japan 18 463 1.0× 276 0.7× 440 1.3× 78 0.6× 103 0.8× 30 1.4k
Hong Shu China 22 245 0.5× 177 0.5× 780 2.4× 59 0.4× 125 1.0× 94 1.4k
Masato Watanabe Japan 20 216 0.5× 130 0.3× 316 1.0× 80 0.6× 273 2.1× 85 1.4k

Countries citing papers authored by Kenneth Ng

Since Specialization
Citations

This map shows the geographic impact of Kenneth Ng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth Ng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth Ng more than expected).

Fields of papers citing papers by Kenneth Ng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth Ng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth Ng. The network helps show where Kenneth Ng may publish in the future.

Co-authorship network of co-authors of Kenneth Ng

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth Ng. A scholar is included among the top collaborators of Kenneth Ng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth Ng. Kenneth Ng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choudhury, Noura J., W. Victoria Lai, Alex Makhnin, et al.. (2024). A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung Cancer. Clinical Cancer Research. 30(17). 3697–3703. 14 indexed citations
2.
Lebow, Emily S., Kelly Fitzgerald, Narek Shaverdian, et al.. (2024). Phase II Trial of Concurrent Durvalumab and Radiation Therapy for Locally Advanced Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 120(2). S57–S58.
3.
4.
Paik, Paul K., Rachel K. Kim, Linda S. Ahn, et al.. (2020). A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers. Clinical Cancer Research. 26(8). 1796–1802. 10 indexed citations
5.
Guthrie, Gregory, Hester Vlaardingerbroek, Barbara J. Stoll, et al.. (2016). Multi-omic profiles of hepatic metabolism in TPN-fed preterm pigs administered new generation lipid emulsions. Journal of Lipid Research. 57(9). 1696–1711. 15 indexed citations
6.
Pietanza, M. Catherine, Anya M. Litvak, Anna M. Varghese, et al.. (2016). A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer. Lung Cancer. 99. 23–30. 55 indexed citations
7.
Ng, Kenneth, Barbara J. Stoll, Shaji Chacko, et al.. (2015). Vitamin E in New‐Generation Lipid Emulsions Protects Against Parenteral Nutrition–Associated Liver Disease in Parenteral Nutrition–Fed Preterm Pigs. Journal of Parenteral and Enteral Nutrition. 40(5). 656–671. 69 indexed citations
8.
Vlaardingerbroek, Hester, Kenneth Ng, Barbara J. Stoll, et al.. (2014). New generation lipid emulsions prevent PNALD in chronic parenterally fed preterm pigs. Journal of Lipid Research. 55(3). 466–477. 65 indexed citations
9.
Fury, Matthew G., Eric J. Sherman, Stephanie Smith–Marrone, et al.. (2014). Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III–IVB head and neck squamous cell carcinoma (HNSCC). Annals of Oncology. 25(3). 689–694. 22 indexed citations
10.
Goh, Wilson Wen Bin, et al.. (2013). Variant screening of the serum amyloid A1 gene and functional study of the p.Gly90Asp variant for its role in atherosclerosis. Atherosclerosis. 227(1). 112–117. 10 indexed citations
11.
Zhong, Liang, Kenneth Ng, John Carson Allen, et al.. (2013). Myocardial contractile dysfunction associated with increased 3-month and 1-year mortality in hospitalized patients with heart failure and preserved ejection fraction. International Journal of Cardiology. 168(3). 1975–1983. 15 indexed citations
12.
Paik, Paul K., Leonard P. James, Gregory J. Riely, et al.. (2011). A phase 2 study of weekly albumin-bound paclitaxel (Abraxane®) given as a two-hour infusion. Cancer Chemotherapy and Pharmacology. 68(5). 1331–1337. 22 indexed citations
13.
Tan, Louis C.S., et al.. (2008). Bromocriptine use and the risk of valvular heart disease. Movement Disorders. 24(3). 344–349. 33 indexed citations
14.
Ng, Kenneth, Zoran Popović, Richard W. Troughton, et al.. (2005). Comparison of left ventricular diastolic function after on-pump versus off-pump coronary artery bypass grafting. The American Journal of Cardiology. 95(5). 647–650. 8 indexed citations
15.
Azzoli, Christopher G., Vincent A. Miller, Kenneth Ng, et al.. (2003). Gemcitabine-Induced Peripheral Edema. American Journal of Clinical Oncology. 26(3). 247–251. 21 indexed citations
16.
Downey, Robert J., Kenneth Ng, Mark G. Kris, et al.. (2002). A phase II trial of chemotherapy and surgery for non-small cell lung cancer patients with a synchronous solitary metastasis. Lung Cancer. 38(2). 193–197. 76 indexed citations
17.
Downey, Robert J. & Kenneth Ng. (2001). The Management of Non-Small-Cell Lung Cancer with Oligometastases. Chest Surgery Clinics of North America. 11(1). 121–132. 5 indexed citations
18.
Sim, S, et al.. (2001). Induction chemotherapy plus three-dimensional conformal radiation therapy in the definitive treatment of locally advanced non-small-cell lung cancer. International Journal of Radiation Oncology*Biology*Physics. 51(3). 660–665. 40 indexed citations
19.
Miller, Vincent A., Kenneth Ng, Lee M. Krug, et al.. (2000). Phase I trial of docetaxel and vinorelbine in patients with advanced nonsmall cell lung carcinoma. Cancer. 88(5). 1045–1050. 11 indexed citations
20.
Miller, V. A., Kenneth Ng, Stefan C. Grant, et al.. (1997). Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer. Annals of Oncology. 8(12). 1269–1271. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshimitsu Yamaoka Breakdown of academic impact, for papers by Hang Zheng Breakdown of academic impact, for papers by William G. Nelson Breakdown of academic impact, for papers by Loredana Santo Breakdown of academic impact, for papers by Peng Chen Breakdown of academic impact, for papers by Nilgün Kapucuoğlu Breakdown of academic impact, for papers by C Shih Breakdown of academic impact, for papers by Tatsuya Rikimaru Breakdown of academic impact, for papers by Hong Shu Breakdown of academic impact, for papers by Masato Watanabe
Rankless by CCL
2026